| SERVICE |
RECOMMENDATIONS |
|
PREVENTIVE SERVICES |
| Outreach programmes |
4.2.8 Better management, monitoring and support systems should be
introduced for outreach services. Outreach services should clearly identify their aims and
objectives and collect data on number of contacts made, the effect of contact, costs per
contact and on turnover of clients. 4.3.11 Purchasers should
consider the needs of young people at risk of drug misuse and those who are misusing drugs
within a comprehensive local assessment of need. Meeting the needs of young drug misusers
is likely to include:
- youth services which are aware of and responsive to possible drug
problems;
- drugs services specifically dedicated to young people;
- arrangements for access, where appropriate to
"mainstream" drug services.
ACUTE, SHORT TERM CARE |
| Hospital Drug Dependence Unit care; acute assessment facilities |
5.10.14 Purchasers should: - recognise
that specialist inpatient (and residential) detoxification programmes can have significant
impact on certain types of drug misusers who may not benefit from outpatient
detoxification.
- ensure that those needing detoxification are admitted within
a specified time from identification of need. Given the levels of drug related and
psychological problems likely to be present in clients in need of residential care, prompt
access is likely to be important.
- gather cost information on in and outpatient detoxification
programmes and monitor outcomes to inform them of the relative cost effectiveness of the
different approaches.
- health authorities should identify from local needs
assessments, the likely demand for inpatient services, and contract for that level in
advance so that such services can undertake proper planning to meet the expected level of
need. |
| Generic A&E services |
4.5.4 All Accident & Emergency (A&E) Department staff
should receive basic drug awareness training. - Purchasers
should discuss with A&E providers the practicalities of collecting data on drug misuse
attendance at A and E Departments.
- A&E Departments should display posters and have leaflets
available on drug misuse, health promotion and harm minimisation, and where to get help
from local drug treatment services.
- Purchasers should explore with A&E providers the scope
for developing needle exchanges in A&E Departments. |
| Hospital detoxification; Community detoxification services;
Community drug crisis intervention services |
5.5.10 Purchasers should ensure detoxification services are always
complemented by counselling and social support. Purchasers
should establish outcome criteria for detoxification, based on evidence of safety and
minimal discomfort, and the percentages of patients who complete the treatment and who go
on to further treatment.
SUPPORT AND REHABILITATION |
| Inpatient unit care |
5.10.14 Purchasers should: - recognise
that specialist inpatient (and residential) detoxification programmes can have significant
impact on certain types of drug misusers who may not benefit from outpatient
detoxification
- ensure that those needing detoxification are admitted within
a specified time from identification of need. Given the levels of drug related and
psychological problems likely to be present in clients in need of residential care, prompt
access is likely to be important.
- gather cost information on in and outpatient detoxification
programmes and monitor outcomes to inform them of the relative cost effectiveness of the
different approaches.
Health authorities should:
- identify, from local needs assessments, the likely demand for
inpatient services, and contract for that level in advance so that such services can
undertake proper planning to meet the expected level of need. |
|
Residential care:
Minnesota model
Christian
Therapeutic communities
Other models
|
5.9.13 - Purchasers should ensure
access to residential care for those likely to benefit.
- Given the levels of drug related and psychological problems
likely to be present in clients in need of residential care, prompt access is likely to be
important. Purchasers should ensure admission within a specified time from identification
of need.
- Purchasers need to be able to meet the varied needs of their
clients. Given the range of distinct philosophical approaches to rehabilitation adopted by
centres in England, they should have access to centres of the three main types:
therapeutic communities, 12 step and Christian based houses.
- Until more comprehensive and longer term outcome data become
available from the National Treatment Outcome Research Study, purchasers will need to look
at the rates of retention in the services they purchase. The Task Force considered that,
as a preliminary measure, more than 50% should remain in treatment at the end of 4weeks -
a target already achieved by some centres. Purchasers should take steps to follow up
people who drop out to establish why and thus inform future purchasing strategies. |
| Methadone reduction programmes |
5.6.11 - Reduction programmes
should review the status of clients and their treatment contract on a regular basis,
egonce a month, according to the length of the programme.
- Purchasers should consider how to ensure clients who have
become drug free can have access to appropriate support through further outpatient
attendances, community projects or self-help groups such as Narcotics Anonymous. |
| Methadone maintenance programmes |
5.7.16 Purchasers should: - ensure
that the programme content, structure and setting of methadone maintenance programmes
reflects the needs of clients;
- expect programmes to review the status of the client on a
regular basis (eg every 3months) to see if they have reached a stage where they are
readier to contemplate reduction leading to abstinence.
- monitor the impact of treatment on other problem domains (eg
crime etc).
- Study the longer term results from the National Treatment
Outcomes Research Study to see if structured programmes produce better outcomes, and to
identify optimum dispensing arrangements. |
| Hospital outpatient and other community-based clinics |
6.3.8 Health and Social Services purchasers should have a dedicated
resource to deal with drug misuse and should work with others to ensure organisational
barriers do not slow down speed of assessment and response. Contracts
between purchasers and providers against which overall performance is assessed should
incorporate specific quality standards which ensure individual clients:
- have the right to an assessment of individual need (where
appropriate) within a specified number of working days;
- have the right of access to specialist services within a
specified maximum waiting time;
- have the right to respect for privacy, dignity and
confidentiality, and an explanation of any (exceptional) circumstances in which
information will be divulged to others;
- have the right of access to a complaints procedure;
- have the right to full information about treatment options
and informed involvement in making decisions on treatment;
- have the right, when referred to consultant, to be referred
for a second opinion, in consultation with their GP;
- can expect the right to an individual care and treatment
plan;
DATs should initially monitor local performance standards, but this
should be with a view to development of national targets.
Opening hours
6.4.3
Purchasers should identify when users need services to be open,
taking account of the needs of particular groups such as young people, and reflect this in
contracts.
Opening times should be widely publicised. |
| Counselling within the NHS and voluntary sector street agencies and
community drug projects |
5.4.15 Counselling should be recognised as a core component of drug
treatment and not just an optional subsidiary to other treatments. There is a need for purchasers and providers to distinguish clearly between
structured counselling approaches, with clearly defined goals, and information and advice
giving.
Delivery of structured counselling needs training and skills and
purchasers should encourage this by requiring services to increase their numbers of
accredited counsellors.
Further research is needed to evaluate the effectiveness of
different counselling approaches. |
| Services for stimulant users |
5.11.5 Provision should be made for services to be able to deal
with the treatment needs of amphetamine drug misusers heavily dependent on amphetamines.
5.11.28 All specialist drug agencies should be prepared to offer
treatment to primary cocaine users.
Services should provide rapid access to treatment.
Purchasers need to monitor that cocaine drug misusers are getting
appropriate and adequate treatment. |
| Services specifically for young drug misusers |
4.3.11 Purchasers should consider the needs of young people at risk
of drug misuse and those who are misusing drugs within a comprehensive local assessment of
need. Meeting the needs of young drug misusers is likely to include: - youth services which are aware of and responsive to possible drugs
problems;
- drugs services specifically dedicated to young people;
- arrangements for access, where appropriate, to
"mainstream" drug services.
4.4.6 The Task Force endorsed the recommendations of the Social
Services Inspectorate. Social Services Departments should build on the positive start
which may have been made and make sure that adequate priority is given to services for
drug misusers and especially young people misusing drugs. |
|
| Services specifically for women |
6.5.3 Purchasers and providers should take account of particular
needs (eg childcare facilities for drug misusing mothers) and reflect these in contracts. |
| Services for ethnic minorities |
6.5.6 Purchasers should work with representatives of ethnic
minority groups to identify and take account of any particular service needs they identify
and reflect these in contracts. |
| Care in Family Health Services settings - GP surgeries |
4.7.19 GPs have responsibility for the physical health needs of
drug misusers within the provision of general medical services and should be encouraged to
identify drug misuse, promote harm minimisation and where appropriate refer to specialist
services. The process of "shared care", with
appropriate support for GPs, should be available as widely as possible. Health authorities
should encourage its expansion to enable GPs to take overall clinical responsibility for
drug misusers and agree with a specialist a treatment plan which may involve the GP
prescribing substitute opiate drugs.
GPs should be sufficiently skilled to identify a problem drug
misuser who may be consulting them for other, perhaps related, problems. This may require
a programme of specialised training for some GPs.
GPs should know to whom they can refer in a crisis and for ongoing
support, either from specialist drug workers, such as community psychiatric nurses,
regularly attending their clinics, or by access to a named key worker in a local
specialist agency.
The service provided by the GP should be agreed between the Local
Medical Committee and specialist services and should clearly set out the respective roles
of the GP and the specialist services, and the support the GP can expect in delivering the
service.
Purchasers should ensure that GPs have straightforward access to
urine testing facilities.
Where they have concerns about compliance with consumption
arrangements GPs should have access to facilities where supervised consumption can take
place.
The agreement between the Local Medical Committee and specialist
services for the provision of shared care should include arrangements for referral,
assessment and management. Purchasers should monitor local arrangements and ensure
adequate controls are in place.
Where the service is defined as exceeding the requirements of
general medical services, following consultation and agreement with the profession, the
question of additional payment for the delivery of a specialist service needs to be
considered. |
| Care in Family health Service settings - pharmacies |
4.8.11 The Department of Health should consider setting up pilot
projects to investigate the potential for pharmacies to expand the range of services they
offer to drug misusers, including the supervised consumption of controlled drugs or other
medication on the premises where appropriate. Results should be used to draw up guidelines
and ensure appropriate training is available for participating pharmacies and their staff. |
| Care in Family Health Service settings - Health Authorities |
4.8.11 Health Authorities should: - ensure
a comprehensive coverage of needle-exchange facilities, using pharmacy outlets as well as
specialist agency services, outreach workers and potentially A&E departments;
- consider the extent to which participating pharmacies can
deliver health promotion messages. These could include advice to protect others as well as
drug misusers themselves, for example on storing controlled drugs to prevent harm to
children and to educate misusers on the risk of, and methods to avoid, overdose;
- take steps to improve links between pharmacies and
prescribers and feedback in both directions, and ensure participating pharmacies have
effective links with specialist services for advice. |
|
| Free standing needles/syringe exchanges |
5.3.19 Purchasers should: - ensure
comprehensive local coverage by syringe exchange schemes.
- ensure that minimum service specifications for exchange
schemes include provision of basic health checks for clients and that exchange scheme
staff receive training to enable them to provide these.
- require all exchange schemes to collect basic client data.
They should also collect information on costs including cost per exchange.
- agree targets with syringe exchange schemes on volume of
clients, frequency of visit, duration of contact and percentage of referrals to treatment.
Details of targets should be set locally.
- review arrangements for delivering HepatitisB vaccinations
locally and monitor progress towards universal vaccination of drug service clients. |
| Self help family help groups/networks |
5.2.11 Purchasers should be aware of the possible benefits of self
help networks and should encourage the development of a wide range of self-help groups and
self help treatments. Information about existing groups such
as Narcotics Anonymous and Families Anonymous, and services such as ADFAM, should be made
available in all treatment settings.
Where possible, self help groups should be evaluated more
rigorously. |
| Arrest and bailee referral schemes |
4.10.11 HM Inspectors of Constabulary should take steps to
encourage full and consistent use of cautioning of drug misusers by local police. Arrest referral schemes should be provided at each police station. DATs
should consider whether there are cost benefits to provision of support from specialist
drug workers.
DATs should explore ways of monitoring the effectiveness of
cautioning and arrest referral schemes as a means of reducing re-offending.
DATs should encourage their police representative to consider
training needs of police surgeons so they are equipped with the skills to manage the
clinical needs of drug misusers within police custody. |
| Probation linked care |
4.11.10 Through their membership of DATs, probation services should
consider ways of maximising joint working and, where appropriate, pooling resources with
other statutory bodies such as health and local authorities to maximise the benefits for
treatment of drug misusers in their care. |
| Prison throughcare/release schemes |
4.13.5 Drug misusers should have immediate access to appropriate
treatment programmes on release. This is essential to maximising the treatment opportunity
we hope will be available within prisons, as well as reducing the risk of overdose
inherent in a return to use of street drugs after a period of abstinence. In those areas with prisons, DATs should review the arrangements for managing
drug misusers on release and ensuring that effective arrangements exist for referring drug
misusers to appropriate services. |
| Social Services |
4.4.6 The Task Force endorsed the recommendations of the Social
Services Inspectorate report. Social Services Departments should build on the positive
start which many have made and make sure that adequate priority is given to services for
drug misusers and especially young people misusing drugs. |
| Alcohol dependency services |
6.5.12 Purchasers and providers should ensure that people working
in both drug and alcohol treatment services are aware of the need to identify and respond
to overlapping alcohol and drug problems. |
| Psychiatric service |
6.5.10 Purchasers and providers should ensure that people working
in both drugs and mental illness services are aware of the need to identify and respond to
problems of combined psychiatric illness and drug misuse. |
Other health care:
Maternity;
Dentistry;
Hepatitis B vaccination
|
4.6.6 Maternity staff should receive basic drug awareness training.
Purchasers should explore the need for maternity drug liaison
workers.
5.3.19 Purchasers should review arrangements for delivering
Hepatitis B vaccinations locally and monitor progress towards universal vaccination of
drug service clients. |
| Training |
6.6.7 Professional bodies should review the extent to which they
have implemented the Advisory Council on the Misuse of Drugs' 1990 recommendations.
Purchasers should require providers to examine skill levels of staff
working with drug misusers and make sure that service budgets include enough to enable the
right training to be undertaken.
6.7.6 People appointed as service directors should have good
management skills and in post training should be made available to them, and other
managers, as appropriate.
Voluntary sector management committees and NHS Trust line managers
should recognise their own responsibilities to ensure these directors perform effectively. |
|
| Note: Agencies can provide multiple services in a
single community setting. Many of the Polkinghorne recommendations - such as those on
services user rights and service quality management - apply across settings and services. |